Recent advances in genomics, proteomics, and metabolomics are providing deeper insights into disease mechanisms. These technologies allow for the identification of biomarkers that can predict disease risk and progression. Advances in immunotherapy are also promising, particularly for pediatric cancers and autoimmune diseases.
